Would you rather read or hear about the latest #regulatory guidance updates regarding #invitro #druginteractions studies in #drugdevelopment? Why not both! The 2020 Regulatory updates webinar, presented by VP of Scientific Consulting Dr. Brian Ogilvie, covers critical topics including:
– An overview of the major updates in the new 2020 #FDA Guidance for Industry
– How to design #preclinical studies to meet the expectations of each agency’s guidance documents
– Impacts on in vitro DDI study design and interpretation
– Views of the worldwide DDI guidance landscape
– A comparison of FDA / EMA / PMDA guidance documents
Or get a PDF download of the companion #scientificposter that details the differences between each agency and spells out what exactly has been updated in the finalized guidance. Request access to the poster here: https://lnkd.in/gVncXrn or watch the full webinar: https://lnkd.in/gVWpZUC
